
1. j trop med hyg. 2013 jun;88(6):1124-1129. doi: 10.4269/ajtmh.12-0739. epub
2013 apr 15.

selection antimalarial drug resistance intermittent preventive treatment
of infants children (ipti/c) senegal.

ndiaye m, tine r, faye b, ndiaye jl, lo ac, sylla k, abiola a, dieng y, ndiaye d,
hallett r, gaye o, alifrangis m.

our study investigated possible impact sp-ipt given infants and
children prevalence sp-resistant haplotypes plasmodium
falciparum genes pfdhfr pfdhps, comparing sites without ipti/c. p.
falciparum positive samples (n = 352) collected children < 5 years were
analyzed determine prevalence sp resistance-related haplotypes by
nested pcr followed sequence-specific oligonucleotide probe-enzyme-linked
immunosorbent assay. prevalence pfdhfr triple mutant haplotype (cirn) 
increased groups, significantly ipti/c group 41% 
65% 2011 (p = 0.005). conversely, pfdhps 437g mutation decreased both
groups 44.6% 28.6% (p = 0.07) 66.7% 47.5% (p = 0.02) 
2010 2011 control ipti/c groups, respectively. weak trend
for decreasing prevalence quadruple mutants (triple pfdhfr + pfdhps 437g) 
noted groups (p = 0.15 p = 0.34). two cross-sectional
surveys significant changes observed sp resistance-related
genes.

doi: 10.4269/ajtmh.12-0739 
pmcid: pmc3752812
pmid: 23589534  [indexed medline]

